Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jingling oral liquid for ADHD
ChiCTR-IPR-17012293Phase 4Recruiting
- Sponsor
- Beijing Anding Hospital
- Start
- Oct 2014
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Jianjining in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Beijing Anding Hospital. Primary endpoint: ADHDRS IV-Parent. Started Oct 2014; status: recruiting.
02
Drugs
Jianjining
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on ChiCTR-IPR-17012293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17012293.